The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10447 malaria professionals are enjoying the free benefits of MalariaWorld today

randomised controlled trials

Mass drug administrations with dihydroartemisinin-piperaquine and single low dose primaquine to eliminate Plasmodium falciparum have only a transient impact on Plasmodium vivax: Findings from randomised controlled trials

February 14, 2020 - 16:53 -- Open Access
Author(s): 
Phommasone K, van Leth F, von Seidlein L, et al.
Reference: 
PLoS ONE 15(2): e0228190

Mass administrations of antimalarial drugs (MDA) have reduced the incidence and prevalence of P. falciparum infections in a trial in the Greater Mekong Subregion. Here we assess the impact of the MDA on P. vivax infections.

Subscribe to RSS - randomised controlled trials